London, 23 July 2018 – Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK), the multinational generic pharmaceutical company, will announce its interim financial results for the six months ended 30 June 2018 on Wednesday 15 August 2018.
23 July 2018
Corporate, Press Release
A presentation and webcast for analysts will be held at 9.30am BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD, with registration and coffee from 9.15am.
To join via conference call please dial:
UK Toll Free Number: 020 3936 2999
US Toll Free Number: 1 855 9796 654
Standard International Access: +44 20 3936 2999
Password: 911652
The results presentation and a webcast recording of the event will be available on the Company's website at www.hikma.com or http://webcast.openbriefing.com/hikma_interim_results_2018/.
Playback facility:
A playback of the conference call will be available after the presentation.
United Kingdom - 020 3936 3001
United States - 1 845 709 8569
All other locations - + 44 20 3936 3001
Replay code: 338668